Early Increase of CD4+ CD45RA+ and CD4+ CD95- Cells with Conserved Repertoire Induced by Anti-retroviral Therapy in HIV-infected Patients

Overview

Journal Clin Exp Immunol

Publisher Oxford University Press

Specialty Allergy & Immunology

Date 1998 Feb 24

PMID 9472655

Citations 4

Authors

G Silvestri

C Munoz-Calleja

P Bagnarelli

G Piedimonte

M Clementi

M Montroni

Affiliations

Soon will be listed here.

Abstract

Administration of anti-retroviral drugs induces a decrease of viral load associated with increase of CD4+ cell count in most HIV-infected patients. To investigate the early changes in CD4+ cell phenotype induced by anti-retroviral therapy, six patients with CD4+ cell count > 100/mm3 and never treated with anti-HIV therapy were enrolled and blood samples collected several times within 14 days from the initiation of therapy with Zidovudine plus Didanosine. CD4+ cell count and HIV viraemia were investigated at each time point, as well as the expression of CD45RA, CD45RO and CD95/Fas molecules on CD4+ cells, and the T cell receptor (TCR) Vbeta repertoire of CD4+ cells. All patients showed a rapid and dramatic decrease in viral load with a corresponding increase of CD4+ cell count. The main remodelling of CD4+ cell subpopulations took place in the first 14 days of therapy, and consisted of: (i) increased CD4+CD45RA+/CD4+CD45RO+ ratio; (ii) decrease of CD95/Fas expression. The rise in absolute number of CD4+CD45RA+ cells was paralleled by an increase of CD4+CD95/Fas- cells and accounted for most of the early increment of CD4+ cell count. The TCR Vbeta repertoire of CD4+ cells was conserved after anti-HIV therapy, with the exception of two patients with expanded CD4+Vbeta12+ cells, which also tested CD45RA+ and CD95/Fas-. These experiments show that newcomer CD4+ lymphocytes are CD45RA+CD95/Fas- cells, suggesting that blocking HIV replication causes an early and antigen-independent proliferation of possibly 'naive' cells unprimed for CD95/Fas-mediated apoptosis. These cells expressed a conserved and widespread TCR repertoire, suggesting that their capability for antigenic recognition is intact.

Citing Articles

Ongoing burden of disease and mortality from HIV/CMV coinfection in Africa in the antiretroviral therapy era.

Adland E, Klenerman P, Goulder P, Matthews P Front Microbiol. 2015; 6:1016.

PMID: 26441939 PMC: 4585099. DOI: 10.3389/fmicb.2015.01016.

The HIV-1 protease inhibitor nelfinavir activates PP2 and inhibits MAPK signaling in macrophages: a pathway to reduce inflammation.

Wallet M, Reist C, Williams J, Appelberg S, Guiulfo G, Gardner B J Leukoc Biol. 2012; 92(4):795-805.

PMID: 22786868 PMC: 3441314. DOI: 10.1189/jlb.0911447.

Induction of CD95 ligand expression on T lymphocytes and B lymphocytes and its contribution to apoptosis of CD95-up-regulated CD4+ T lymphocytes in macaques by infection with a pathogenic simian/human immunodeficiency virus.

Sasaki Y, Ami Y, Nakasone T, Shinohara K, Takahashi E, Ando S Clin Exp Immunol. 2000; 122(3):381-9.

PMID: 11122244 PMC: 1905812. DOI: 10.1046/j.1365-2249.2000.01327.x.

Early reduction of the over-expression of CD40L, OX40 and Fas on T cells in HIV-1 infection during triple anti-retroviral therapy: possible implications for lymphocyte traffic and functional recovery.

Sousa A, Chaves A, Doroana M, Antunes F, Victorino R Clin Exp Immunol. 1999; 116(2):307-15.

PMID: 10337023 PMC: 1905269. DOI: 10.1046/j.1365-2249.1999.00872.x.

References

Tough D, Sprent J . Turnover of naive- and memory-phenotype T cells. J Exp Med. 1994; 179(4):1127-35. PMC: 2191431. DOI: 10.1084/jem.179.4.1127. View

Westendorp M, Frank R, Ochsenbauer C, Stricker K, Dhein J, Walczak H . Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature. 1995; 375(6531):497-500. DOI: 10.1038/375497a0. View

Sprent J, Tough D . Lymphocyte life-span and memory. Science. 1994; 265(5177):1395-400. DOI: 10.1126/science.8073282. View

Wei X, Ghosh S, Taylor M, Johnson V, Emini E, Deutsch P . Viral dynamics in human immunodeficiency virus type 1 infection. Nature. 1995; 373(6510):117-22. DOI: 10.1038/373117a0. View

Ho D, Neumann A, Perelson A, Chen W, Leonard J, Markowitz M . Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature. 1995; 373(6510):123-6. DOI: 10.1038/373123a0. View

Roos M, Miedema F, Koot M, Tersmette M, Schaasberg W, Coutinho R . T cell function in vitro is an independent progression marker for AIDS in human immunodeficiency virus-infected asymptomatic subjects. J Infect Dis. 1995; 171(3):531-6. DOI: 10.1093/infdis/171.3.531. View

Pantaleo G, Fauci A . Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden. J Immunol. 1995; 154(10):5555-66. View

DOBRESCU D, Kabak S, Mehta K, Suh C, Asch A, Cameron P . Human immunodeficiency virus 1 reservoir in CD4+ T cells is restricted to certain V beta subsets. Proc Natl Acad Sci U S A. 1995; 92(12):5563-7. PMC: 41736. DOI: 10.1073/pnas.92.12.5563. View

Cossarizza A, Ortolani C, Mussini C, Borghi V, Guaraldi G, Mongiardo N . Massive activation of immune cells with an intact T cell repertoire in acute human immunodeficiency virus syndrome. J Infect Dis. 1995; 172(1):105-12. DOI: 10.1093/infdis/172.1.105. View

10.

McIlroy D, Autran B, Cheynier R, Wain-Hobson S, Clauvel J, Oksenhendler E . Infection frequency of dendritic cells and CD4+ T lymphocytes in spleens of human immunodeficiency virus-positive patients. J Virol. 1995; 69(8):4737-45. PMC: 189281. DOI: 10.1128/JVI.69.8.4737-4745.1995. View

11.

Cossarizza A, Ortolani C, Mussini C, Guaraldi G, Mongiardo N, Borghi V . Lack of selective V beta deletion in CD4+ or CD8+ T lymphocytes and functional integrity of T-cell repertoire during acute HIV syndrome. AIDS. 1995; 9(6):547-53. DOI: 10.1097/00002030-199506000-00003. View

12.

Maldarelli F, Sato H, Berthold E, Orenstein J, Martin M . Rapid induction of apoptosis by cell-to-cell transmission of human immunodeficiency virus type 1. J Virol. 1995; 69(10):6457-65. PMC: 189546. DOI: 10.1128/JVI.69.10.6457-6465.1995. View

13.

DOBRESCU D, Ursea B, Pope M, Asch A, Posnett D . Enhanced HIV-1 replication in V beta 12 T cells due to human cytomegalovirus in monocytes: evidence for a putative herpesvirus superantigen. Cell. 1995; 82(5):753-63. DOI: 10.1016/0092-8674(95)90472-7. View

14.

Oyaizu N, McCloskey T, Than S, Hu R, Pahwa S . Mechanism of apoptosis in peripheral blood mononuclear cells of HIV-infected patients. Adv Exp Med Biol. 1995; 374:101-14. DOI: 10.1007/978-1-4615-1995-9_9. View

15.

Tuosto L, Gilardini Montani M, Lorenzetti S, Cundari E, Moretti S, Lombardi G . Differential susceptibility to monomeric HIV gp120-mediated apoptosis in antigen-activated CD4+ T cell populations. Eur J Immunol. 1995; 25(10):2907-16. DOI: 10.1002/eji.1830251030. View

16.

McCloskey T, Oyaizu N, Kaplan M, Pahwa S . Expression of the Fas antigen in patients infected with human immunodeficiency virus. Cytometry. 1995; 22(2):111-4. DOI: 10.1002/cyto.990220206. View

17.

Badley A, McElhinny J, Leibson P, Lynch D, Alderson M, Paya C . Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes. J Virol. 1996; 70(1):199-206. PMC: 189805. DOI: 10.1128/JVI.70.1.199-206.1996. View

18.

Lynch D, Ramsdell F, Alderson M . Fas and FasL in the homeostatic regulation of immune responses. Immunol Today. 1995; 16(12):569-74. DOI: 10.1016/0167-5699(95)80079-4. View

19.

OBRIEN W, Hartigan P, Martin D, Esinhart J, Hill A, Benoit S . Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS. N Engl J Med. 1996; 334(7):426-31. DOI: 10.1056/NEJM199602153340703. View

20.

Kelleher A, Carr A, Zaunders J, Cooper D . Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir. J Infect Dis. 1996; 173(2):321-9. DOI: 10.1093/infdis/173.2.321. View